Literature DB >> 1879927

Increase in tumor necrosis factor alpha- and interleukin-6-secreting cells in peripheral blood mononuclear cells from subjects infected with Mycobacterium tuberculosis.

T Ogawa1, H Uchida, Y Kusumoto, Y Mori, Y Yamamura, S Hamada.   

Abstract

We detected and quantified tumor necrosis factor alpha (TNF-alpha) and interleukin-6 (IL-6) from monocytes/macrophages (M phi) in the peripheral blood of subjects from three different population groups, i.e., tuberculin-negative healthy subjects, tuberculin-positive healthy subjects, and patients with active pulmonary tuberculosis. TNF-alpha or IL-6 activity in the culture supernatant of these cells was determined by the cytotoxicity of murine L-929 cells or by enzyme-linked immunosorbent assay, respectively. Detection and enumeration of cells secreting either TNF-alpha or IL-6 were performed by an adaptation of the enzyme-linked immunospot assay. Monocytes/M phi from tuberculin-positive healthy subjects or patients with tuberculosis showed higher TNF-alpha- and IL-6-producing activities than those from tuberculin-negative healthy subjects. The number of TNF-alpha- and IL-6-secreting cells in either lipopolysaccharide- or muramyl dipeptide-stimulated mononuclear cells from tuberculin-positive healthy subjects and patients was significantly higher than that in cells from the tuberculin-negative healthy subjects.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1879927      PMCID: PMC258129          DOI: 10.1128/iai.59.9.3021-3025.1991

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  19 in total

Review 1.  Detection of human cytokine-secreting cells in distinct anatomical compartments.

Authors:  C Czerkinsky; G Andersson; B Ferrua; I Nordström; M Quiding; K Eriksson; L Larsson; K Hellstrand; H P Ekre
Journal:  Immunol Rev       Date:  1991-02       Impact factor: 12.988

Review 2.  Interleukin-6: an overview.

Authors:  J Van Snick
Journal:  Annu Rev Immunol       Date:  1990       Impact factor: 28.527

Review 3.  Interleukin-1 and its biologically related cytokines.

Authors:  C A Dinarello
Journal:  Adv Immunol       Date:  1989       Impact factor: 3.543

4.  Direct stimulation of monocyte release of interleukin 1 by mycobacterial protein antigens.

Authors:  R S Wallis; H Fujiwara; J J Ellner
Journal:  J Immunol       Date:  1986-01       Impact factor: 5.422

5.  An endotoxin-induced serum factor that causes necrosis of tumors.

Authors:  E A Carswell; L J Old; R L Kassel; S Green; N Fiore; B Williamson
Journal:  Proc Natl Acad Sci U S A       Date:  1975-09       Impact factor: 11.205

Review 6.  Cachectin/tumor necrosis factor and other cytokines in infectious disease.

Authors:  K J Tracey; A Cerami
Journal:  Curr Opin Immunol       Date:  1989-02       Impact factor: 7.486

Review 7.  Neutrophil-activating peptide-1/interleukin 8, a novel cytokine that activates neutrophils.

Authors:  M Baggiolini; A Walz; S L Kunkel
Journal:  J Clin Invest       Date:  1989-10       Impact factor: 14.808

8.  Enumeration of cytokine-secreting cells at the single-cell level.

Authors:  B J Skidmore; S A Stamnes; K Townsend; A L Glasebrook; K C Sheehan; R D Schreiber; J M Chiller
Journal:  Eur J Immunol       Date:  1989-09       Impact factor: 5.532

9.  Expression of tumor necrosis factor in vitro by human mononuclear phagocytes stimulated with whole Mycobacterium bovis BCG and mycobacterial antigens.

Authors:  S E Valone; E A Rich; R S Wallis; J J Ellner
Journal:  Infect Immun       Date:  1988-12       Impact factor: 3.441

10.  Bacteria-infected fibroblasts have enhanced susceptibility to the cytotoxic action of tumor necrosis factor.

Authors:  G R Klimpel; R Shaban; D W Niesel
Journal:  J Immunol       Date:  1990-07-15       Impact factor: 5.422

View more
  37 in total

1.  Opsonizing antibodies (IgG1) up-regulate monocyte proinflammatory cytokines tumour necrosis factor-alpha (TNF-alpha) and IL-6 but not anti-inflammatory cytokine IL-10 in mycobacterial antigen-stimulated monocytes-implications for pathogenesis.

Authors:  R Hussain; H Shiratsuchi; M Phillips; J Ellner; R S Wallis
Journal:  Clin Exp Immunol       Date:  2001-02       Impact factor: 4.330

2.  An Afghan child with deep vein thrombosis.

Authors:  R Gupta; M Brueton; J Fell; H Lyall
Journal:  J R Soc Med       Date:  2003-06       Impact factor: 5.344

3.  TNF-alpha antagonist therapy modify the tuberculin skin test response.

Authors:  Tulin Cagatay; Zeki Kilicaslan; Penbe Cagatay; Munevver Mertsoylu; Ziya Gulbaran; Reyhan Yildiz; Leyla Pur; Sevil Kamali; Ahmet Gul
Journal:  Rheumatol Int       Date:  2010-03-27       Impact factor: 2.631

4.  Association of antigen-stimulated release of tumor necrosis factor-alpha in whole blood with response to chemotherapy in patients with pulmonary multidrug-resistant tuberculosis.

Authors:  Seok-Yong Eum; Ye-Jin Lee; Jin-Hong Min; Hyun-Kyung Kwak; Min-Sun Hong; Ji-Hye Kong; Soo-Hee Hwang; Seung-Kyu Park; Jason J Leblanc; Laura E Via; Clifton E Barry; Sang-Nae Cho
Journal:  Respiration       Date:  2010-02-10       Impact factor: 3.580

5.  Monocytes modulate enhancement of HIV-1 replication by Mycobacterium tuberculosis.

Authors:  C J De Haas; N M de Vos; M R Visser; H Snippe; J Verhoef
Journal:  Clin Exp Immunol       Date:  1998-02       Impact factor: 4.330

6.  Cross-modulation by transforming growth factor beta in human tuberculosis: suppression of antigen-driven blastogenesis and interferon gamma production.

Authors:  C S Hirsch; R Hussain; Z Toossi; G Dawood; F Shahid; J J Ellner
Journal:  Proc Natl Acad Sci U S A       Date:  1996-04-16       Impact factor: 11.205

7.  Potential role of interleukin 6 in reactive thrombocytosis and acute phase response in pulmonary tuberculosis.

Authors:  E Unsal; S Aksaray; D Köksal; T Sipit
Journal:  Postgrad Med J       Date:  2005-09       Impact factor: 2.401

Review 8.  [Immunology of tuberculosis: impact on the development of novel vaccines].

Authors:  T Ulrichs; S H E Kaufmann
Journal:  Internist (Berl)       Date:  2003-11       Impact factor: 0.743

9.  Thalidomide treatment reduces tumor necrosis factor alpha production and enhances weight gain in patients with pulmonary tuberculosis.

Authors:  J M Tramontana; U Utaipat; A Molloy; P Akarasewi; M Burroughs; S Makonkawkeyoon; B Johnson; J D Klausner; W Rom; G Kaplan
Journal:  Mol Med       Date:  1995-05       Impact factor: 6.354

10.  Determinants of natural immunity against tuberculosis in an endemic setting: factors operating at the level of macrophage-Mycobacterium tuberculosis interaction.

Authors:  A N Gaikwad; Sudhir Sinha
Journal:  Clin Exp Immunol       Date:  2008-03       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.